Nikhil Lalwani - 12 Aug 2025 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
12 Aug 2025
Net transactions value
-$4,894,573
Form type
4
Filing time
14 Aug 2025, 17:48:48 UTC
Previous filing
25 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lalwani Nikhil PRESIDENT & CEO, Director C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook 14 Aug 2025 0001822629

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale $4,894,573 -56,960 -12% $85.93 411,219 12 Aug 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold in multiple trades at prices ranging from $84.40 to $87.47. The price reported above reflects the weighted average sales price.